Phase 1 Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer

Shilpa Gupta, Luke T Nordquist, Mark T Fleming, William R Berry, Jingsong Zhang, Sharon L Ervin, Joel R Eisner, Edwina S Baskin-Bey and Neal D Shore